A narrative review of influenza: a seasonal and pandemic disease

M Moghadami - Iranian journal of medical sciences, 2017‏ - pmc.ncbi.nlm.nih.gov
Influenza is an acute respiratory disease caused by the influenza A or B virus. It often occurs
in outbreaks and epidemics worldwide, mainly during the winter season. Significant …

Characteristics of viral pneumonia in the COVID-19 era: an update

P Pagliano, C Sellitto, V Conti, T Ascione, S Esposito - Infection, 2021‏ - Springer
Influenza virus, rhinovirus, and adenovirus frequently cause viral pneumonia, an important
cause of morbidity and mortality especially in the extreme ages of life. During the last two …

Polydopamine-based nanomedicines for efficient antiviral and secondary injury protection therapy

N Yin, Z Zhang, Y Ge, Y Zhao, Z Gu, Y Yang, L Mao… - Science …, 2023‏ - science.org
Viral infections continue to threaten human health. It remains a major challenge to efficiently
inhibit viral infection while avoiding secondary injury. Here, we designed a multifunctional …

Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study

G Moreno, A Rodríguez, LF Reyes, J Gomez… - Intensive care …, 2018‏ - Springer
Purpose To determine clinical predictors associated with corticosteroid administration and
its association with ICU mortality in critically ill patients with severe influenza pneumonia …

Antivirals for treatment of severe influenza: a systematic review and network meta-analysis of randomised controlled trials

Y Gao, G Guyatt, TM Uyeki, M Liu, Y Chen, Y Zhao… - The Lancet, 2024‏ - thelancet.com
Background The optimal antiviral drug for treatment of severe influenza remains unclear. To
support updated WHO influenza clinical guidelines, this systematic review and network meta …

Rationale for azithromycin in COVID-19: an overview of existing evidence

I Gyselinck, W Janssens… - BMJ Open …, 2021‏ - bmjopenrespres.bmj.com
Azithromycin has rapidly been adopted as a repurposed drug for the treatment of COVID-19,
despite the lack of high-quality evidence. In this review, we critically appraise the current …

Systematic review of respiratory viral pathogens identified in adults with community-acquired pneumonia in Europe

Y Alimi, WS Lim, L Lansbury, J Leonardi-Bee… - Journal of Clinical …, 2017‏ - Elsevier
Community-acquired pneumonia (CAP) is an important respiratory disease and the fifth
leading cause of mortality in Europe. The development of molecular diagnostic tests has …

Influenza infections and emergent viral infections in intensive care unit

B Cantan, CE Luyt… - Seminars in respiratory …, 2019‏ - thieme-connect.com
Critically ill patients are admitted to an intensive care unit (ICU) for multiple reasons. In this
study, we aim to analyze the current evidence and findings associated with influenza and …

Safety and effectiveness of neuraminidase inhibitors for influenza treatment, prophylaxis, and outbreak control: a systematic review of systematic reviews and/or meta …

MK Doll, N Winters, C Boikos… - Journal of …, 2017‏ - academic.oup.com
Objectives To review evidence from systematic reviews and/or meta-analyses (SR/MAs)
regarding neuraminidase inhibitor (NI) safety and effectiveness. Methods We conducted an …

Influenza-induced thrombocytopenia is dependent on the subtype and sialoglycan receptor and increases with virus pathogenicity

AJG Jansen, T Spaan, HZ Low, D Di Iorio… - Blood …, 2020‏ - ashpublications.org
Thrombocytopenia is a common complication of influenza virus infection, and its severity
predicts the clinical outcome of critically ill patients. The underlying cause (s) remain …